Communication study for people with limited time left
This study looks at how doctors and patients talk about care when someone has a serious illness. It aims to improve communication in hospice outpatient clinics.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a terminal illness and likely have 6 months or less to live
- You are 18 years old or older
- You can speak Mandarin or Taiwanese
- You are able to use electronic devices like a tablet or phone
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new AI tool designed to help patients and families talk about their values and needs with doctors and nurses during palliative care. It is for people with serious illnesses who are already receiving outpatient palliative care or home care services.
This trial tests if a chatbot can help caregivers of older adults with pneumonia by improving their knowledge, attitudes, and caregiving skills. It's for family or informal caregivers who live with the patient and use a smartphone.
This trial tests whether mobile instant messaging can help gynecological cancer patients and their partners. If you and your spouse are managing treatment together, this study may offer extra support.
This trial tests whether a chatbot can help family members of older adults in care homes learn about advance care planning. If you care for a frail or prefrail older relative and haven't had much discussion about end-of-life wishes, this study may help you start those important conversations.
This study tests a program to help doctors and patients have better conversations about palliative care. It is for adults with advanced cancer that cannot be cured, their doctors, and hospital staff who might help start these talks.
This study tests if a LINE chatbot can help you manage side effects from your EGFR-TKI targeted therapy. If you have advanced lung cancer and are taking a pill like gefitinib or osimertinib, this chatbot might help you track symptoms and communicate with your care team.
Hear when a new Communication trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.